J&J says vaccine works against delta variant; WHO pushes Western nations to accept travelers with Chinese vaccines: COVID-19 updates – USA TODAY
Concern about the highly transmissible delta COVID-19 variant and its spread among the unvaccinated continues to grow as U.S. cases rise, but positive news about vaccines' ability to fight the virus keeps coming.
Thursday, Johnson & Johnson said its one-dose shot protects against the delta variant, citing lab tests of vaccine recipients' blood. And amid concerns their shot might require a booster, the company said its immune response lasts eight months and counting.
Public health experts say the variant poses the most danger in regions where vaccinations are sparse.
The variants “are able to find any gaps in our protection,” Dr. Hilary Babcock of Washington University at St. Louis said, pointing to how hospital beds and intensive care units in Missouri’s least-vaccinated southwestern...